Page 53 - MI-1-1

Microbes & Immunity The feature of bladder cancer stem cells

and facilitates differentiation of myoblasts by sponging miR- 88. Kozovska Z, Patsalias A, Bajzik V, et al. ALDH1A inhibition
133a. J Cell Physiol. 2018;233(6):4643-4651. sensitizes colon cancer cells to chemotherapy. BMC Cancer.
2018;18(1):656.
doi: 10.1002/jcp.26230
78. Tao T, Yuan S, Liu J, et al. Cancer stem cell-specific expression doi: 10.1186/s12885-018-4572-6
profiles reveal emerging bladder cancer biomarkers and 89. Falso MJ, Buchholz BA, White RW. Stem-like cells in bladder
identify circRNA_103809 as an important regulator in cancer cell lines with differential sensitivity to cisplatin.
bladder cancer. Aging (Albany NY). 2020;12(4):3354-3370. Anticancer Res. 2012;32(3):733-738.
doi: 10.18632/aging.102816 90. Pastushenko I, Blanpain C. EMT Transition states during
79. Chen X, Xie R, Gu P, et al. Long noncoding RNA LBCS tumor progression and metastasis. Trends Cell Biol.
inhibits self-renewal and chemoresistance of bladder cancer 2019;29(3):212-226.
stem cells through epigenetic silencing of SOX2. Clin Cancer doi: 10.1016/j.tcb.2018.12.001
Res. 2019;25(4):1389-1403.
91. Serrano Nájera G, Weijer CJ. The evolution of gastrulation
doi: 10.1158/1078-0432.Ccr-18-1656 morphologies. Development. 2023;150(7):dev200885
80. Zhan Y, Chen Z, He S, et al. Long non-coding RNA SOX2OT doi: 10.1242/dev.200885
promotes the stemness phenotype of bladder cancer cells by
modulating SOX2. Mol Cancer. 2020;19(1):25. 92. Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT,
MET, plasticity, and tumor metastasis. Trends Cell Biol.
doi: 10.1186/s12943-020-1143-7 2020;30(10):764-776.
81. Rusu P, Shao C, Neuerburg A, et al. GPD1 Specifically marks doi: 10.1016/j.tcb.2020.07.003
dormant glioma stem cells with a distinct metabolic profile.
Cell Stem Cell. 2019;25(2):241-257.e8. 93. Coghlin C, Murray GI. Current and emerging concepts in
tumour metastasis. J Pathol. 2010;222(1):1-15.
doi: 10.1016/j.stem.2019.06.004
doi: 10.1002/path.2727
82. Duan JJ, Cai J, Gao L, Yu SC. ALDEFLUOR activity, ALDH
isoforms, and their clinical significance in cancers. J Enzyme 94. Zhao D, Besser AH, Wander SA, et al. Cytoplasmic p27
Inhib Med Chem. 2023;38(1):2166035. promotes epithelial-mesenchymal transition and tumor
metastasis via STAT3-mediated Twist1 upregulation.
doi: 10.1080/14756366.2023.2166035 Oncogene. 2015;34(43):5447-5459.
83. Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 doi: 10.1038/onc.2014.473
aldehyde oxidizing enzymes: The aldehyde dehydrogenase
superfamily. Expert Opin Drug Metab Toxicol. 95. Wang G, Dai Y, Li K, et al. Deficiency of Mettl3 in bladder
2008;4(6):697-720. cancer stem cells inhibits bladder cancer progression and
angiogenesis. Front Cell Dev Biol. 2021;9:627706.
doi: 10.1517/17425255.4.6.697
doi: 10.3389/fcell.2021.627706
84. Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y. Unraveling the
roles of CD44/CD24 and ALDH1 as cancer stem cell markers 96. Teeuwssen M, Fodde R. Wnt signaling in ovarian cancer
in tumorigenesis and metastasis. Sci Rep. 2017;7(1):13856. stemness, EMT, and therapy resistance. J Clin Med.
2019;8(10):1658.
doi: 10.1038/s41598-017-14364-2
doi: 10.3390/jcm8101658
85. Ma I, Allan AL. The role of human aldehyde dehydrogenase
in normal and cancer stem cells. Stem Cell Rev 97. Zhang J, Kuang Y, Wang Y, Xu Q, Ren Q. Notch-4 silencing
Rep. 2011;7(2):292-306. inhibits prostate cancer growth and EMT via the NF-κB
pathway. Apoptosis. 2017;22(6):877-884.
doi: 10.1007/s12015-010-9208-4
doi: 10.1007/s10495-017-1368-0
86. Croker AK, Rodriguez-Torres M, Xia Y, et al. Differential
functional roles of ALDH1A1 and ALDH1A3 in mediating 98. Zhang J, Tian XJ, Xing J. Signal transduction pathways
metastatic behavior and therapy resistance of human breast of EMT induced by TGF-β, SHH, and WNT and their
cancer cells. Int J Mol Sci. 2017;18(10):2039. crosstalks. J Clin Med. 2016;5(4):41
doi: 10.3390/ijms18102039 doi: 10.3390/jcm5040041
87. Wang YC, Yo YT, Lee HY, et al. ALDH1-bright epithelial 99. Vantaku V, Donepudi SR, Ambati CR, et al. Expression of
ovarian cancer cells are associated with CD44 expression, ganglioside GD2, reprogram the lipid metabolism and EMT
drug resistance, and poor clinical outcome. Am J Pathol. phenotype in bladder cancer. Oncotarget. 2017;8(56):95620-
2012;180(3):1159-1169. 95631.
doi: 10.1016/j.ajpath.2011.11.015 doi: 10.18632/oncotarget.21038

Volume 1 Issue 1 (2024) 47 doi: 10.36922/mi.2377